Quick Answer
Medpace Holdings, Inc. reported Cash And Cash Equivalents At Carrying Value of $497.05 million for the year ending 2025.
- Medpace Holdings, Inc. showed a decrease of -25.8% in Cash And Cash Equivalents At Carrying Value from 2024 to 2025.
- This data is from Medpace Holdings, Inc.'s annual report (Form 10-K), filed with the SEC on February 10, 2026.
- XBRL data for this metric is available from 2015 to 2025 (11 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Over the full 11 years of available data (2015 to 2025), Medpace Holdings, Inc.'s Cash And Cash Equivalents At Carrying Value has grown by 3,240.4%.
- Historical annual values: Fiscal year 2025: $497.05 million | Fiscal year 2024: $669.44 million | Fiscal year 2023: $245.45 million | Fiscal year 2022: $28.27 million | Fiscal year 2021: $461.30 million | Fiscal year 2020: $277.77 million | Fiscal year 2019: $131.92 million | Fiscal year 2018: $23.28 million | Fiscal year 2017: $26.49 million | Fiscal year 2016: $37.10 million | Fiscal year 2015: $14.88 million.
- Data sourced from SEC EDGAR public filings as of June 24, 2026.
Last verified: